Home › NDC Lookup › RxCUI directory › RxCUI 2727418

Codeine phosphate 2 MG/ML / dexbrompheniramine maleate 0.2 MG/ML Oral Solution — RxCUI 2727418

Name: Codeine phosphate 2 MG/ML / dexbrompheniramine maleate 0.2 MG/ML Oral Solution (RxCUI 2727418)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2727418 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2727418

Official nameCodeine phosphate 2 MG/ML / dexbrompheniramine maleate 0.2 MG/ML Oral Solution

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known ascodeine phosphate 10 MG / dexbrompheniramine maleate 1 MG per 5 ML Oral Solution; codeine phosphate 10 MG / dexbrompheniramine maleate 1 MG in 5 mL Oral Solution

FDA products mapped1

Package NDCs mapped2

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Codeine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Codeine Sulfate tablets are used to treat mild to moderate pain — think post-injury pain or pain after a procedure — when over-the-counter options like ibuprofen or acetaminophen h...
You take codeine Sulfate tablets by mouth, typically every 4 hours as needed for pain. The good news is you can take it with or without food — studies show a meal doesn't meaningfu...
How do I take it, and does it matter if I take it with food?
The most common things people notice are drowsiness, dizziness, nausea, constipation, and sweating — these are typical opioid effects. The ones to take seriously and call 911 about...

📖 Read our full Codeine guide →

🕸️ Concept Web — How Codeine phosphate 2 MG/ML / dexbrompheniramine m... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Codeine phosphate 2 MG/ML / dexbrompheniramine maleate 0.2 MG/ML Oral Solution RxCUI 2727418 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 5

The active substance itself — no strength, form, or brand attached yet.
- Codeine 2670 IN
- Dexbrompheniramine 22696 IN
- Codeine / dexbrompheniramine 2727411 MIN
- Codeine phosphate 2672 PIN
- Dexbrompheniramine maleate 48936 PIN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Codeine / dexbrompheniramine Oral Solution 2727414 SCDF
- Codeine phosphate / dexbrompheniramine maleate Oral Solution 2727417 SCDFP
- Codeine / dexbrompheniramine Oral Liquid Product 2727413 SCDG
- Codeine / dexbrompheniramine Oral Product 2727412 SCDG
- Codeine phosphate / dexbrompheniramine maleate Oral Liquid Product 2727416 SCDGP
- Codeine phosphate / dexbrompheniramine maleate Oral Product 2727415 SCDGP
- Oral Solution 316968 DF
- Oral Liquid Product 1151137 DFG
- +1 more in this family
Clinical & branded drugs 2

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Codeine phosphate 2 MG/ML 832866 SCDC
- Dexbrompheniramine maleate 0.2 MG/ML 1299142 SCDC

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Codeine phosphate 2 MG/ML SCDC · 832866
Dexbrompheniramine maleate 0.2 MG/ML SCDC · 1299142
Codeine / dexbrompheniramine Oral Solution SCDF · 2727414
Codeine phosphate / dexbrompheniramine maleate Oral Solution SCDFP · 2727417
Codeine / dexbrompheniramine Oral Liquid Product SCDG · 2727413
Codeine / dexbrompheniramine Oral Product SCDG · 2727412
Codeine phosphate / dexbrompheniramine maleate Oral Liquid Product SCDGP · 2727416
Codeine phosphate / dexbrompheniramine maleate Oral Product SCDGP · 2727415

📦 FDA Products & Package NDCs

1 product · 2 package NDCs

2 package NDCs map to RxCUI 2727418 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
50991-0540-16	473 mL in 1 BOTTLE (50991-540-16)	Duratuss AC	Poly Pharmaceuticals, Inc.	2025-09-08
50991-0540-20	20 mL in 1 BOTTLE (50991-540-20)	Duratuss AC	Poly Pharmaceuticals, Inc.	2025-09-08

Observed labelers: Poly Pharmaceuticals, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.